General/Other

MarketReports.com | Pharmaceuticals & Healthcare |  General/Other

Tensions Rising between Branded Drugmakers and Health Plans Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 31-Mar-2012 Format: PDF Pages: 5 Publisher: GlobalData More...

Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 29-Feb-2012 Format: PDF Pages: 79 Publisher: GBI Research More...

Xigris Failed to Show a Survival Benefit - A Voluntary Market Withdrawal Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 30-Nov-2011 Format: PDF Pages: 5 Publisher: GlobalData More...

European Debt Crisis - Impact on Healthcare Industry Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 19-Dec-2011 Format: PDF Pages: 10 Publisher: GlobalData More...

Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 30-Sep-2011 Format: PDF Pages: 13 Publisher: GlobalData More...

Comparative Analysis of Marketed Drugs in Major Indications - Patent Cliff to Set Off Intense Price Competition in High Volume Markets Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 31-Aug-2011 Format: PDF Pages: 195 Publisher: GBI Research More...

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 06-Jul-2011 Format: PDF Pages: 132 Publisher: GBI Research More...

Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 17-Sep-2011 Format: PDF Pages: 86 Publisher: GBI Research More...

Global Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016) Price Single User $5,650.00 Multi User $8,150.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: Dec-2011 Format: PDF Pages: 345 Publisher: MarketsandMarkets Table of Contents More...

Emerging Pharmaceutical Markets 2012 Please click here for more information or to purchase this report at our partner store Published: June 2011 Pages: 222 Publisher: Select Biosciences The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost factors. Mainly due to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research study provides extensive and coherent information about pharmaceutical markets in emerging countries. It also gives a detailed statistical and analytical review on the demographics, macroeconomic indicators, disease profile, key drivers and restraints of the emerging pharmaceutical markets.

Top 10 Healthcare Trends in 2011 Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 31-Mar-2011 Format: PDF Pages: 194 Publisher: GBI Research More...

Global: Pharmaceuticals Industry Guide 2011 Price: $995.00 (€779.05) ($1,194.00 (€934.86) Including VAT at 20%) Publication Date: 28-Mar-2011 Please click here for more information or to purchase this report at our partner store An essential resource for top-level data and analysis covering the Global Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%) Publication Date: 31-Mar-2011 Please click here for more information or to purchase this report at our partner store Overview of cost-cutting, M&A and R&D trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Pharmaceuticals: Global Industry Almanac 2010 Price: $2,995.00 (€2,344.99) ($3,594.00 (€2,813.99) Including VAT at 20%) Publication Date: 31-Jan-2011 Please click here for more information or to purchase this report at our partner store Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Pharmaceuticals: Global Industry Guide 2010 Price: $1,495.00 (€1,170.54) ($1,794.00 (€1,404.65) Including VAT at 20%) Publication Date: 31-Jan-2011 Please click here for more information or to purchase this report at our partner store Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2010 Price: $1,495.00 (€1,170.54) ($1,794.00 (€1,404.65) Including VAT at 20%) Publication Date: 31-Jan-2011 Please click here for more information or to purchase this report at our partner store Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Will 2011 Spell a Brighter Year for the Pharmaceutical Companies? Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 15-Mar-2011 Format: PDF Pages: 6 Publisher: GlobalData More...

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Dec-2010 Format: PDF Pages: 177 Publisher:GBI Research Sample Pages GBI Research, the leading business intelligence provider, has released its latest report, “Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” that provides key data, information and analysis of the major trends and issues affecting the Pharmaceutical market. The report provides a comprehensive insight into the history of Pharmaceutical Industry Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions, its uses, efficiency as well as their limitations. The report also provides a detailed analysis of Pharmaceutical Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions in terms of its market size, and the major market drivers and barriers.. The report also looks into Pharmaceutical drug pipeline along with analysis on the pipeline by indication, phase of development and geography of development. More...

New Approaches to Gaining Market Access for Pharmaceuticals Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 30-Sep-2010 Please click here for more information or to purchase this report at our partner store Market access is becoming more challenging for new pharmaceuticals, especially expensive treatments that drive up drug spending. More emphasis is being placed on value for money, with economic evaluation becoming part of the equation.

Big Pharma Performance Before, During and Beyond the Global Recession Price: $7,600.00 (€5,950.56) ($9,120.00 (€7,140.68) Including VAT at 20%) Publication Date: 27-Nov-2009 Please click here for more information or to purchase this report at our partner store A comparative analysis of leading pharmaceutical company sales dynamics over the period 200514

Mapping the Healthcare Landscape - Bringing pharmaceuticals into focus Price: $7,600.00 (€5,950.56) ($9,120.00 (€7,140.68) Including VAT at 20%) Publication Date: 12-Nov-2009 Please click here for more information or to purchase this report at our partner store Diversification is one strategy Big Pharma is using to contend with the oncoming patent cliff, however, Datamonitor has analyzed ten sectors within healthcare and concluded that remaining pharma-focused will lead to maximum revenue growth.

2010 Trends to Watch: Knowledge Process Outsourcing Price: $1,895.00 (€1,483.73) ($2,274.00 (€1,780.47) Including VAT at 20%) Publication Date: 25-Dec-2009 Please click here for more information or to purchase this report at our partner store Technology markets are changing fast. This brief is essential reading for you to identify and track the key forces shaping the prospects for your business.

Pharma Goes Cloud Gazing (Analyst Opinion) Price: $150.00 (€117.45) ($180.00 (€140.93) Including VAT at 20%) Publication Date: 23-Dec-2009 Please click here for more information or to purchase this report at our partner store A Datamonitor analyst opinion piece on the life sciences industry's use of cloud computing.

Global Pharmaceuticals Price: $250.00 (€195.74) ($300.00 (€234.89) Including VAT at 20%) Publication Date: 07-Dec-2009 Please click here for more information or to purchase this report at our partner store Market size, share and segmentation data plus detailed analysis and company information for the global pharmaceuticals industry.

Pricing & Reimbursement in Emerging Markets Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 27-Aug-2010 Please click here for more information or to purchase this report at our partner store Much of the recent growth in sales in emerging markets has been fuelled by an expansion in public sector health insurance coverage, which means that drug reimbursement is much more widespread than in the past.

Pharmaceutical Company Outlook to 2014 Price: $7,600.00 (€5,950.56) ($9,120.00 (€7,140.68) Including VAT at 20%) Publication Date: 23-Dec-2009 Please click here for more information or to purchase this report at our partner store Assess the outlook for the PharmaVitae universe of leading Rx pharma companies to 2014, in terms of both sales and operating performance. Analyze the industry by peer set, balance of launches / expiries, and therapeutic and molecule type focus.

Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 17-May-2010 Please click here for more information or to purchase this report at our partner store The pharmaceutical industry is challenged with information integration and mapping across the various business processes. This information challenge, along with other issues & regulatory compliance costs are compelling pharmaceutical companies to look for alternatives to remain competitive. This report provides an overview of the BI market in the pharma sector including its size and growth followed by the current trends of BI technologies & adoption of BI tools across key pharmaceutical processes.

The Global Active Pharmaceutical Ingredients (API) Market: Evaluating challenges, opportunities, innovations and the market environment Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 09-Feb-2010 Please click here for more information or to purchase this report at our partner store Companies use APIs at a number of stages of pharmaceutical development, including in stability sample testing, general analytical testing and method development, as good manufacturing practice in clinical trials, and as source materials for manufacturing marketed drugs. Sourcing APIs from low-cost suppliers is a key strategy for companies pressured by the emerging 'patent cliff'. The model of vertical integration that dominated the pharmaceutical industry in the past century is now being broken up.

Pharmaceuticals: Global Industry Overview 2010 Price: $1,495.00 (€1,170.54) ($1,794.00 (€1,404.65) Including VAT at 20%) Publication Date: 25-Feb-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals: Global Industry Overview is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Healthcare: Global Industry Overview 2010 Price: $745.00 (€583.31) ($894.00 (€699.97) Including VAT at 20%) Publication Date: 17-Feb-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Healthcare: Global Industry Overview is an essential resource for top-level data and analysis covering the healthcare industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

2010 Guide to the Life Sciences Industry for Technology Providers Price: $1,895.00 (€1,483.73) ($2,274.00 (€1,780.47) Including VAT at 20%) Publication Date: 12-Mar-2010 Please click here for more information or to purchase this report at our partner store Overview of the life sciences industry and key opportunities for technology vendors

Pharmaceutical Key Trends 2010 - The patent cliff dominates but growth opportunities remain Price: $11,400.00 (€8,925.85) ($13,680.00 (€10,711.02) Including VAT at 20%) Publication Date: 17-Mar-2010 Please click here for more information or to purchase this report at our partner store An overview of key trends shaping the pharmaceutical industry today, as well as drivers and resistors that are set to play a central role in the future as companies look to increase sales and boost profitability.

Global Pharmaceuticals, Biotechnology & Life Sciences Price: $250.00 (€195.74) ($300.00 (€234.89) Including VAT at 20%) Publication Date: 22-Mar-2010 Please click here for more information or to purchase this report at our partner store Market size and segmentation data plus detailed analysis and company information for the global pharmaceuticals, biotechnology & life sciences industry.

Global Life Sciences Tools & Services Price: $250.00 (€195.74) ($300.00 (€234.89) Including VAT at 20%) Publication Date: 22-Mar-2010 Please click here for more information or to purchase this report at our partner store Market size and segmentation data plus detailed analysis and company information for the global life sciences tools & services industry.

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide 2010 Price: $995.00 (€779.05) ($1,194.00 (€934.86) Including VAT at 20%) Publication Date: 31-Mar-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Pharmaceuticals: Global Industry Almanac 2010 Price: $2,995.00 (€2,344.99) ($3,594.00 (€2,813.99) Including VAT at 20%) Publication Date: 27-Apr-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Pharmaceuticals - Global Group of Eight (G8) Industry Guide 2010 Price: $1,495.00 (€1,170.54) ($1,794.00 (€1,404.65) Including VAT at 20%) Publication Date: 27-Apr-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Pharmaceuticals: Global Industry Guide 2010 Price: $1,495.00 (€1,170.54) ($1,794.00 (€1,404.65) Including VAT at 20%) Publication Date: 27-Apr-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Pharmaceuticals - Top 5 Emerging Markets Industry Guide 2010 Price: $995.00 (€779.05) ($1,194.00 (€934.86) Including VAT at 20%) Publication Date: 27-Apr-2010 Please click here for more information or to purchase this report at our partner store Datamonitor's Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

MarketReports.com | Pharmaceuticals & Healthcare |  General/Other

© 2012 MarketReports.com  Contact Us | Privacy Policy | Terms & Conds